library.onepin.app/mk-677 Peptide Education Library
Education only, not medical advice 21+ Every dose is an example to finalize with a licensed provider
Growth Hormone Not FDA-approved · research compound

MK-677

Ibutamoren · MK677 · Nutrobal

10-25mg – 25 mg Oral daily, preferably before bed

MK-677 (ibutamoren mesylate) is a non-peptide, orally active growth hormone secretagogue that mimics the action of ghrelin by binding to the growth hormone secretagogue receptor (GHS-R1a). Unlike growth hormone releasing peptides (GHRPs), MK-677 is not a peptide and has excellent oral bioavailability. It stimulates the pituitary gland to release growth hormone (GH) in a pulsatile, physiological pattern, and significantly increases circulating levels of both GH and IGF-1 without suppressing the hypothalamic-pituitary axis.

Quick Start
Route
Oral
Start low
10-25mg Oral
Frequency
daily, preferably before bed
Timing
Can be taken fasted or with food. Taking before bed may maximize sleep-related GH pulse amplification.

Oral: Bedtime dosing preferred (GH pulse during sleep, reduces daytime hunger). Take with or without food. Continuous or 5-on-2-off.

Start here. Every protocol below is ordered lowest-first. Begin at the smallest effective dose, hold about a week to assess tolerance, and step up only if needed.

Tiered Protocols · lowest first
Conservative start
10-25mg · Oral · daily, preferably before bed
conservative starter
10-25mg
daily, preferably before bed
Standard
Standard Oral
12.5-25 mg · Oral · Daily
human clinical trial · Nass et al. 2008 (Ann Intern Med)
Oral ghrelin-mimetic; no injection. Night dosing helps tolerate the appetite bump.
12.5-25 mg
Daily
Intermediate
Higher Dose
25 mg · Oral · Daily
anecdotal · community
Above 25 mg gives diminishing GH returns but more edema/insulin resistance.
25 mg
Daily
01

How it works

Binds to the ghrelin/growth hormone secretagogue receptor (GHS-R1a) in the hypothalamus and pituitary, mimicking endogenous ghrelin. This stimulates growth hormone-releasing hormone (GHRH) neurons and directly activates pituitary somatotrophs, producing pulsatile GH release that mirrors the natural secretory pattern.

Amplifies GH pulse amplitude without altering pulse frequency, preserving the physiological GH secretion pattern. Also reduces somatostatin (GH-inhibiting hormone) tone, further facilitating GH release. The result is sustained elevation of both GH and IGF-1 levels without the tachyphylaxis seen with continuous GH administration.

As a ghrelin mimetic, MK-677 activates hypothalamic appetite centers (NPY/AgRP neurons), increasing hunger and food intake. It also modulates glucose metabolism through GHS-R1a-mediated effects on pancreatic islets and hepatic glucose output, which can worsen insulin sensitivity.

02

What to expect

Early
Days 1–7

Days 1-7: Increased appetite and improved sleep quality are the first noticeable effects. Mild water retention begins. GH/IGF-1 elevation starts within 2-3 days.

03

Evidence

HumanPresent
AnimalPresent
In-vitroPresent

Claims we could not support

No abstract we checked supports these for this molecule at this route. That is not the same as saying they are false — it marks where the evidence is missing.

Dose/route: 10-25mg; Oral; daily, preferably before bed. No checked live PubMed abstract verified this exact displayed dose, route, and frequency for the same molecule/formulation and relevant population.

Mechanism: Binds to the ghrelin/growth hormone secretagogue receptor (GHS-R1a) in the hypothalamus and pituitary, mimicking endogenous ghrelin. This stimulates growth hormone-releasing hormone (GHRH) neurons and directly activates pituitary somatotrophs, producing pulsatile GH release that mirrors the natural secretory pattern.. No checked live PubMed abstract provided an exact-molecule/formulation sentence supporting this source-JSON mechanism claim.

Primary safety claim: Increased appetite and food cravings (very common, 40-60% of users). No checked live PubMed abstract directly verified this source-JSON safety claim at the displayed formulation, route, and regimen.

04

Interactions & stacking

Two different questions: what is documented about running these together, and what is documented about drawing them into the same syringe. A good pharmacological partner can still have to be pinned separately.

Documented together

Testosterone CypionateOften used together in hormone optimization protocols without pharmacological conflict
BPC-157Different mechanisms - GH elevation and tissue repair can be combined safely
EpithalonTelomerase activation and GH elevation address different longevity pathways
PregnenoloneHormone precursor support and GH elevation are independent pathways

Keep separate

SemaglutideMK-677 increases appetite and worsens insulin resistance, directly opposing GLP-1 agonist metabolic benefits
TirzepatideMK-677 appetite stimulation and glucose elevation counteract GIP/GLP-1 agonist effects
SurvodutideMK-677 worsens insulin resistance and increases appetite, opposing GLP-1/glucagon agonist goals
RetatrutideMK-677 appetite stimulation and metabolic effects conflict with triple incretin agonist therapy

Check any specific pair in the Stack & Interaction Checker, which answers both questions separately. Absence of a documented conflict is not evidence of safety.

05

Pharmacokinetics

Illustrative plasma concentration · 22 h
Half-life
~4-6 hours

Effective duration ~24 hours due to sustained IGF-1 elevation

Peak · Tmax
~1-2 hours

Oral

Elimination
~20-30 hours

(parent compound). IGF-1 elevation persists ~24 hours.

Bioavailability

High oral bioavailability (exact % not published, but effective at standard oral doses)

Duration of action
24 hours

GH pulsatility and IGF-1 elevation sustained with daily dosing

Clearance

Hepatic (CYP3A4-mediated metabolism); renal excretion of metabolites

Storage. Store at room temperature in a cool, dry place. Protect from moisture and light. Oral compound - no reconstitution needed.

06

Regulatory status

Investigational compound - never FDA-approved. Clinical development discontinued by Merck. Not a dietary supplement. Listed as a prohibited substance by WADA. Classified as a research chemical.

Put it to work

Calculate, log & track

Open MK-677 straight into OnePin with your vial and dose pre-filled, then let it handle the syringe math and remind you before the vial runs out.

Open MK-677 in the app →

Go deeper

The guide & community

The complete MK-677 walkthrough, real protocol discussion and coaching live inside the BlessUp community on Skool.

Join the community ↗
Open in app Community

Track it in OnePin. Log vials, draws, and protocols in the app.